Prosecution Insights
Last updated: August 17, 2026

Examiner: OGUNTADE, ELIZABETH BISOLA

Tech Center 2800 • Art Units: 1600 1677 1678 2818

This examiner grants 0% of resolved cases

Performance Statistics

0.0%
Allow Rate
-68.0% vs TC avg
19
Total Applications
+0.0%
Interview Lift
629
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

8.8%
§101 Eligibility
13.6%
§102 Novelty
37.6%
§103 Obviousness
31.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18578564 REAGENT FOR PREPARING A CELL SAMPLE Non-Final OA SONY GROUP CORPORATION
18575591 METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
18681989 DETECTION OF BIOACTIVE AGENTS IN A SURROUNDING MEDIUM Non-Final OA Philip Morris Products S.A.
17788429 METHOD FOR DETECTING PROTEIN IN EXTRACELLULAR VESICLES AND EXTRACELLULAR VESICLE MEMBRANE PERMEABILIZATION TREATMENT AGENT Non-Final OA TOSOH CORPORATION
18126108 DEVELOPMENT OF NOVEL APTAMER-BASED BIOSENSOR FOR DETECTION OF SARS-COV-2 PROTEIN IN NASOPHARYNGEAL SWABS OF COVID-19 PATIENTS Final Rejection University of Sharjah
18683345 DEVELOPMENT OF FLEXIBLE PLASMONIC MEMBRANE-BASED SERS PLATFORM FOR MONITORING THE HEALING Non-Final OA Agency for Science, Technology and Research

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month